Effects of antidiabetic agents on steatosis and fibrosis biomarkers in type 2 diabetes: A real‐world data analysis-Reference-Cited by-同舟云学术

Effects of antidiabetic agents on steatosis and fibrosis biomarkers in type 2 diabetes: A real‐world data analysis

Published:2021-02-10 Issue:4 Volume:41 Page:731-742
ISSN:1478-3223
Container-title:Liver International
language:en
Short-container-title:Liver Int

Author:

Colosimo Santo¹²^ORCID,Ravaioli Federico¹^ORCID,Petroni Maria L.¹^ORCID,Brodosi Lucia¹^ORCID,Marchignoli Francesca¹^ORCID,Barbanti Francesca A.¹^ORCID,Sasdelli Anna S.¹^ORCID,Marchesini Giulio¹^ORCID,Pironi Loris¹^ORCID

Affiliation:

1. Department of Medical and Surgical Sciences IRCCS Azienda Ospedaliero‐Universitaria di Bologna Bologna Italy

2. Fondazione IRCSS Ca' Granda Ospedale Maggiore Policlinico di Milano Milan Italy

Publisher

Wiley

Subject

Hepatology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/liv.14799

Reference50 articles.

1. Nonalcoholic Fatty Liver Disease

2. Global burden of NAFLD and NASH: trends, predictions, risk factors and prevention

3. Obesity Is the Most Common Risk Factor for Chronic Liver Disease: Results From a Risk Stratification Pathway Using Transient Elastography

4. The global epidemiology of NAFLD and NASH in patients with type 2 diabetes: A systematic review and meta-analysis

5. EASL–EASD–EASO Clinical Practice Guidelines for the management of non-alcoholic fatty liver disease

Cited by 32 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Natural history and progression of metabolic dysfunction-associated steatotic liver disease;The Lancet Gastroenterology & Hepatology;2024-10

2. Diet and physical exercise as key players to tackle MASLD through improvement of insulin resistance and metabolic flexibility;Frontiers in Nutrition;2024-08-20

3. Glycated haemoglobin is a major predictor of disease severity in patients with NAFLD;Diabetes Research and Clinical Practice;2024-08

4. MAFLD Pandemic: Updates in Pharmacotherapeutic Approach Development;Current Issues in Molecular Biology;2024-06-21

5. Epidemiology of Metabolic Dysfunction-Associated Fatty Liver Disease in Type 2 Diabetes Mellitus and Effects of Antiglycemic Therapy on Liver Fibrosis: A Retrospective Study;Journal of Endocrinology and Metabolism;2024-04